Suboxone Market

研究執行與發布：Coherent Market Insights　·　發布日期 2026-03-12　·　152 頁
由量子訊息有限公司（Quantum Information）在台灣代理銷售與提供授權諮詢。

2026 年市場規模: USD 7.4 Bn
2033 年預估規模: USD 9.6 Bn
年複合成長率 CAGR: 4.1%

以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。

出版商 Coherent Market Insights 產業別 Healthcare & Life Sciences出版日期 2026-03-12頁數 152報告編號 CMI5000

授權報價

Single User Price	$4,500 USD
Enterprise License	$10,000 USD

洽詢購買申請 Sample

完整報告名稱與涵蓋範圍

Suboxone Market, By Type (Branded and Generics), By Formulation (Tablets and Films), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

報告摘要

Suboxone is a prescription opioid medication that is used to inhibit the effects of opioid medications, such as pain relief, which can lead to opioid dependence. Suboxone can be used alone or in combination with other drugs to treat opioid addiction. Suboxone belongs to a drug class known as opioid antagonists, analgesics, and opioid partial agonists. Suboxone is composed of buprenorphine and naloxone. Buprenorphine is an opioid medicine, sometimes known as a narcotic. Naloxone counteracts the benefits of opioid medications, such as pain relief and feelings of well-being, which can lead to opioid dependence. Market Dynamics The increasing product launches for suboxone is expected to drive the growth of global suboxone market over the forecast period. In September 2018, Lannett Co Inc., a global manufacturer of pharmaceutical products, launched five products that include Buprenorphine plus Naloxone Sublingual tablets, and others. Moreover, increasing prescription of opioids in certain regions is expected to drive the market growth over the forecast period. For instance, a research published by EclinicalMedicine, a new open access clinical journal, in November 2021 stated that the U.K. had the highest consumption rate of prescription opioids for pain management per capita in the world, despite declining rates globally. Furthermore, increasing prevalence of chronic pain is expected to drive the growth of global suboxone market over the forecast period. For instance, according to data published by Centers for Disease Control and Prevention in September 2018, stated that an estimated 20.4% of the U.S. adults (50.0 million) had chronic pain and 8.0% of the U.S. adults (19.6 million) had high-impact chronic pain with higher prevalence associated with advancing age in 2016. Key features of the study • This report provides an in-depth analysis of the global suboxone market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players • It profiles key players in the global suboxone market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies • Key companies covered as a part of this study include Indivior PLC, Dr. Reddy’s Laboratories Ltd., Amneal Pharmaceuticals LLC., Mylan N.V., Novartis AG, Teva Pharmaceutical Industries Ltd., Mallinckrodt, Lannett Co Inc., Rhodes Pharmaceuticals L.P., Alvogen, Sun Pharmaceutical Industries Ltd., Alkem Labs, and Hikma Pharmaceuticals PLC • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics • The global suboxone market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global suboxone market Market Segmentation • By Type o Branded o Generics • By Formulation o Tablets o Films • By Distribution Channel o Hospital Pharmacies o Retail Pharmacies o Online Pharmacies • By Regional Insights o North America  U.S.  Canada o Latin America  Brazil  Argentina  Mexico  Rest of Latin America o Europe  Germany  U.K.  Spain  France  Italy  Russia  Rest of Europe o Asia Pacific  China  India  Japan  Australia  South Korea  ASEAN  Rest of Asia Pacific o Middle East  GCC Countries  Israel  Rest of Middle East o Africa  South Africa  North Africa  Central Africa • Key Players Insights o Indivior PLC o Reddy’s Laboratories Ltd. o Amneal Pharmaceuticals LLC. o Mylan N.V. o Novartis AG o Teva Pharmaceutical Industries Ltd. o Mallinckrodt o Lannett Co Inc. o Rhodes Pharmaceuticals L.P. o Alvogen o Sun Pharmaceutical Industries Ltd. o Alkem Labs o Hikma Pharmaceuticals PLC

目錄 Table of Contents

Table of Contents 1. Research Objectives and Assumptions o Research Objectives o Assumptions o Abbreviations 2. Market Purview o Report Description  Market Definition and Scope o Executive Summary  Market Snapshot, By Type  Market Snapshot, By Formulation  Market Snapshot, By Distribution Channel  Market Snapshot, By Region o Coherent Opportunity Map (COM) 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics  Drivers  Restraints  Market Opportunities o Impact Analysis o Market Trends o New Product Launches o Regulatory Scenario o PEST Analysis o PORTER’s Analysis o Key Developments o Brand Analysis o Strategic Agreement, Merger And Acquisitions 4. Global Suboxone Market, By Type, 2026 – 2033, (USD Bn) o Overview  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021-2033  Segment Trends o Branded  Overview  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Generics  Overview  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) 5. Global Suboxone Market, By Formulation, 2026 – 2033, (USD Bn) o Overview  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021-2033  Segment Trends o Tablets  Overview  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Films  Overview  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) 6. Global Suboxone Market, By Distribution Channel, 2026 – 2033, (USD Bn) o Overview  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021-2033  Segment Trends o Hospital pharmacies  Overview  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Retail Pharmacies  Overview  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Online Pharmacies  Overview  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) 7. Global Suboxone Market, By Region, 2026 – 2033, (USD Bn) o Introduction  Market Share Analysis, By Region, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, For Regions, 2021–2033  Regional Trends o North America  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Type, 2021-2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2021-2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (USD Bn) o U.S. o Canada o Latin America  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Type, 2021-2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2021-2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (USD Bn) o Brazil o Mexico o Argentina o Rest of Latin America o Europe  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Type, 2021-2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2021-2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (USD Bn) o UK o Germany o Italy o France o Spain o Russia o Rest of Europe o Asia Pacific  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Type, 2021-2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2021-2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (USD Bn) o China o India o Japan o ASEAN o Australia o South Korea o Rest of Asia Pacific o Middle East  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Type, 2021-2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2021-2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (USD Bn) o GCC o Israel o Rest of Middle East o Africa  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Type, 2021-2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2021-2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2033, (USD Bn)  Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021-2033, (USD Bn) o North Africa o Central Africa o South Africa 8. Competitive Landscape o Indivior PLC.  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Dr. Reddy’s Laboratories Ltd.  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Amneal Pharmaceuticals LLC.  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Mylan N.V.  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Novartis AG  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Teva Pharmaceutical Industries Ltd.  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Mallinckrodt  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Lannett Co Inc.  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Rhodes Pharmaceuticals L.P.  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Alvogen  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Sun Pharmaceutical Industries Ltd.  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Alkem Labs  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Hikma Pharmaceuticals PLC  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies 9. Section o Research Methodology o About Us

提及公司

Indivior PLCReddy’s Laboratories Ltd.Amneal Pharmaceuticals LLC.Mylan N.V.Novartis AGTeva Pharmaceutical Industries Ltd.MallinckrodtLannett Co Inc.Rhodes Pharmaceuticals L.P.AlvogenSun Pharmaceutical Industries Ltd.Alkem LabsHikma Pharmaceuticals PLC

同分類最新報告（醫療與生命科學）

常見問題

這份報告可以先索取樣本嗎？

可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算？

報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付？如何付款？

一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。

量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・聯絡我們